US Patent Issued to Ionis Pharmaceuticals, University of Rochester on Nov. 25 for "Modulation of dystrophia myotonica-protein kinase (DMPK) expression" (California, New York, Massachusetts Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,480,126, issued on Nov. 25, was assigned to Ionis Pharmaceuticals Inc. (Carlsbad, Calif.) and University of Rochester (Rochester, N.Y.).

"Modulation of dystrophia myotonica-protein kinase (DMPK) expression" was invented by Susan M. Freier (San Diego), Charles A. Thornton (Rochester, N.Y.), Thurman Wheeler (Rochester, N.Y.), Seng H. Cheng (Natick, Mass.), Andrew Leger (Boston) and Bruce M. Wentworth (Northborough, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods, compounds, and compositions for reducing expression of a DMPK mRNA and protein in an animal. Also provided herein are methods, compounds, and compositions for pre...